How Can US FDA Bolster Drug Development? The Agency Wants Your Advice

Public meeting scheduled for November to seek recommendations for policies that FDA could implement short-term to promote drug development programs.

microphone

The US Food and Drug Administration is holding a public meeting in November to get stakeholder suggestions on how it can promote innovative and effective drug development programs across multiple therapeutic areas.

More from US FDA

More from Agency Leadership